189 related articles for article (PubMed ID: 1357675)
1. Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of alcohol-preferring rats.
Rezvani AH; Garges PL; Miller DB; Gordon CJ
Pharmacol Biochem Behav; 1992 Sep; 43(1):103-10. PubMed ID: 1357675
[TBL] [Abstract][Full Text] [Related]
2. Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction.
Rezvani AH; Grady DR
Pharmacol Biochem Behav; 1994 May; 48(1):105-10. PubMed ID: 8029280
[TBL] [Abstract][Full Text] [Related]
3. Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine.
Zacny JP; Virus RM; Woolverton WL
Pharmacol Biochem Behav; 1990 Mar; 35(3):637-42. PubMed ID: 1971112
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats.
Rezvani AH; Overstreet DH; Lee YW
Pharmacol Biochem Behav; 1995 Nov; 52(3):615-20. PubMed ID: 8545483
[TBL] [Abstract][Full Text] [Related]
5. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Colado MI; Murray TK; Green AR
Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
[TBL] [Abstract][Full Text] [Related]
6. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
Nash JF; Meltzer HY; Gudelsky GA
J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
[TBL] [Abstract][Full Text] [Related]
7. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
8. The mixed 5-HT 1A/2A receptor drug FG5938 suppresses alcohol drinking while enhancing feeding in P rats.
Piercy KT; Björk AK; Myers RD
Alcohol; 1996; 13(5):521-7. PubMed ID: 8888950
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide synthesis attenuates alcohol consumption in two strains of alcohol-preferring rats.
Rezvani AH; Grady DR; Peek AE; Pucilowski O
Pharmacol Biochem Behav; 1995 Feb; 50(2):265-70. PubMed ID: 7537886
[TBL] [Abstract][Full Text] [Related]
10. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat.
Cassel JC; Riegert C; Rutz S; Koenig J; Rothmaier K; Cosquer B; Lazarus C; Birthelmer A; Jeltsch H; Jones BC; Jackisch R
Neuropsychopharmacology; 2005 Oct; 30(10):1870-82. PubMed ID: 15785779
[TBL] [Abstract][Full Text] [Related]
11. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.
Izco M; Orio L; O'Shea E; Colado MI
Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928
[TBL] [Abstract][Full Text] [Related]
12. Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage.
Bilsky EJ; Hui YZ; Hubbell CL; Reid LD
Pharmacol Biochem Behav; 1990 Dec; 37(4):633-8. PubMed ID: 1982692
[TBL] [Abstract][Full Text] [Related]
13. Reduction of spontaneous alcohol drinking and physical withdrawal by levemopamil, a novel Ca2+ channel antagonist, in rats.
Rezvani AH; Pucilowski O; Grady DR; Janowsky D; O'Brien RA
Pharmacol Biochem Behav; 1993 Oct; 46(2):365-71. PubMed ID: 8265691
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine.
Nencini P; Woolverton WL; Seiden LS
Brain Res; 1988 Aug; 457(1):136-42. PubMed ID: 2901895
[TBL] [Abstract][Full Text] [Related]
15. Suppression of ethanol intake in alcohol-preferring rats by prior voluntary saccharin consumption.
Kampov-Polevoy AB; Overstreet DH; Rezvani AH; Janowsky DS
Pharmacol Biochem Behav; 1995 Sep; 52(1):59-64. PubMed ID: 7501679
[TBL] [Abstract][Full Text] [Related]
16. Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") exhibit increased ethanol consumption and preference.
Izco M; Marchant I; Escobedo I; Peraile I; Delgado M; Higuera-Matas A; Olias O; Ambrosio E; O'Shea E; Colado MI
J Pharmacol Exp Ther; 2007 Sep; 322(3):1003-12. PubMed ID: 17526809
[TBL] [Abstract][Full Text] [Related]
17. Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat.
Gordon CJ; Watkinson WP; O'Callaghan JP; Miller DB
Pharmacol Biochem Behav; 1991 Feb; 38(2):339-44. PubMed ID: 1676171
[TBL] [Abstract][Full Text] [Related]
18. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
Callaway CW; Wing LL; Geyer MA
J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
[TBL] [Abstract][Full Text] [Related]
19. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Colado MI; Williams JL; Green AR
Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
[TBL] [Abstract][Full Text] [Related]
20. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
Colado MI; Green AR
Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
